{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:58:37Z","timestamp":1790456317124,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["CSY-YN-01-2023-009"],"award-info":[{"award-number":["CSY-YN-01-2023-009"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Third People\u2019s Hospital of Chengdu Scientific Research Project","award":["2023PI27"],"award-info":[{"award-number":["2023PI27"]}],"id":[{"id":"https:\/\/ror.org\/00ebdgr24","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303723"],"award-info":[{"award-number":["82303723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer ranks second in global mortality rates, yet its molecular pathogenesis remains incompletely understood. Accumulating evidence indicates that E3 ubiquitin ligases modulate the activity and stability of critical oncoproteins via ubiquitination, positioning these enzymes as promising therapeutic targets for cancer intervention. The E3 ligase Ring finger protein 207 (RNF207), characterized as a regulator involved in heart disease, has not been investigated in colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We constructed RNF207 overexpression and knockdown colorectal cancer cell lines, and investigated the effects of RNF207 on the proliferation and migration of colorectal cancer cells through experiments such as CCK8, colony formation, migration, and invasion assays. In colorectal cancer cell lines and human colorectal cancer tissues, the influence of RNF207 on the Hippo\u2013YAP signaling pathway was extensively investigated. The mechanism by which RNF207 regulates P-YAP and MST1 was explored through Co-IP and ubiquitination experiments. Finally, the effect of RNF207 on the growth of colorectal cancer was investigated in nude mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we demonstrate that elevated RNF207 expression in colorectal tumors correlates with poor prognosis. Functional studies revealed that RNF207 enhances colorectal cancer cell proliferation, migration. Mechanistically, we identified that RNF207 promotes colorectal cancer progression through MST1-dependent regulation of Hippo\u2013YAP signaling. Specifically, RNF207 interacts with MST1 and induces its proteasomal degradation via K48-linked ubiquitination dependent on the activity of E3 ligase, thereby attenuating YAP phosphorylation and activating YAP-driven transcription. Furthermore, the protein level of RNF207 was significantly negatively correlated with the protein levels of MST1 and P-YAP in colorectal tumors, and reducing the expression of RNF207 can effectively inhibit the growth of colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, our findings uncover a novel oncogenic function of RNF207 in colorectal cancer, whereby it facilitates MST1 degradation through K48 ubiquitination, leading to YAP hyper-activation. Targeting RNF207\u2013MST1\u2013YAP axis may represent a potential therapeutic for colorectal cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00535-026-02440-2","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:12:12Z","timestamp":1779912732000},"page":"1431-1449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNF207 promotes colorectal cancer growth by regulating the Hippo\u2013YAP pathway via enhanced MST1 ubiquitination and degradation"],"prefix":"10.1007","volume":"61","author":[{"given":"Meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-2195","authenticated-orcid":false,"given":"Tianqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"2440_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2440_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2440_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051988","author":"J Haynes","year":"2025","unstructured":"Haynes J, Manogaran P. Mechanisms and strategies to overcome drug resistance in colorectal cancer. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26051988.","journal-title":"Int J Mol Sci"},{"key":"2440_CR4","volume":"8","author":"T Yu","year":"2025","unstructured":"Yu T, Zhao J, Li Z, Pan C, Liu J, Zheng K, et al. Research progress on the role of zinc finger protein in colorectal cancer. Cancer Rep (Hoboken). 2025;8:e70123.","journal-title":"Cancer Rep (Hoboken)"},{"key":"2440_CR5","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(18)30488-1","volume":"7","author":"W Chen","year":"2019","unstructured":"Chen W, Xia C, Zheng R, Zhou M, Lin C, Zeng H, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob Health. 2019;7:e257\u201369.","journal-title":"Lancet Glob Health"},{"key":"2440_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu X, Peng Q, Jiang X, Tan S, Yang Y, Yang W, et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp Mol Med. 2023;55:1357\u201370.","journal-title":"Exp Mol Med"},{"key":"2440_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70127","volume":"6","author":"J Li","year":"2025","unstructured":"Li J, Pan J, Wang L, Ji G, Dang Y. Colorectal cancer: pathogenesis and targeted therapy. MedComm. 2025;6:e70127.","journal-title":"MedComm"},{"key":"2440_CR8","doi-asserted-by":"publisher","first-page":"5767535","DOI":"10.1155\/2024\/5767535","volume":"2024","author":"S Mohammadpour","year":"2024","unstructured":"Mohammadpour S, Torshizi Esfahani A, Sarpash S, Vakili F, Zafarjafarzadeh N, Mashaollahi A, et al. Hippo signaling pathway in colorectal cancer: modulation by various signals and therapeutic potential. Anal Cell Pathol (Amst). 2024;2024:5767535.","journal-title":"Anal Cell Pathol (Amst)"},{"key":"2440_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1522705","volume":"13","author":"AO Ajongbolo","year":"2025","unstructured":"Ajongbolo AO, Langhans SA. YAP\/TAZ-associated cell signaling-at the crossroads of cancer and neurodevelopmental disorders. Front Cell Dev Biol. 2025;13:1522705.","journal-title":"Front Cell Dev Biol"},{"key":"2440_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.stem.2020.09.007","volume":"27","author":"V Veschi","year":"2020","unstructured":"Veschi V, Stassi G. The Hippo show must go on: YAP activation as a therapeutic strategy in colorectal cancer. Cell Stem Cell. 2020;27:501\u20132.","journal-title":"Cell Stem Cell"},{"key":"2440_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.375","volume":"4","author":"L Lv","year":"2023","unstructured":"Lv L, Zhou X. Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. MedComm. 2023;4:e375.","journal-title":"MedComm"},{"key":"2440_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102476","volume":"93","author":"SW Chan","year":"2025","unstructured":"Chan SW, Ong C, Hong W. The recent advances and implications in cancer therapy for the Hippo pathway. Curr Opin Cell Biol. 2025;93:102476.","journal-title":"Curr Opin Cell Biol"},{"key":"2440_CR13","doi-asserted-by":"publisher","first-page":"33730","DOI":"10.1074\/jbc.M114.592295","volume":"289","author":"K Roder","year":"2014","unstructured":"Roder K, Werdich AA, Li W, Liu M, Kim TY, Organ-Darling LE, et al. RING finger protein RNF207, a novel regulator of cardiac excitation. J Biol Chem. 2014;289:33730\u201340.","journal-title":"J Biol Chem"},{"key":"2440_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.hrthm.2021.10.005","volume":"19","author":"HA Ledford","year":"2022","unstructured":"Ledford HA, Ren L, Thai PN, Park S, Timofeyev V, Sirish P, et al. Disruption of protein quality control of the human ether-a-go-go related gene K(+) channel results in profound long QT syndrome. Heart Rhythm. 2022;19:281\u201392.","journal-title":"Heart Rhythm"},{"key":"2440_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yjmcc.2016.09.013","volume":"100","author":"W Mizushima","year":"2016","unstructured":"Mizushima W, Takahashi H, Watanabe M, Kinugawa S, Matsushima S, Takada S, et al. The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes. J Mol Cell Cardiol. 2016;100:43\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"2440_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/cvr\/cvac039","volume":"119","author":"L Yuan","year":"2023","unstructured":"Yuan L, Bu S, Du M, Wang Y, Ju C, Huang D, et al. RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1. Cardiovasc Res. 2023;119:183\u201394.","journal-title":"Cardiovasc Res"},{"key":"2440_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1125299","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Wang H, Pan Y, Wang S, Zhang Z, Zhou H, et al. Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer. Front Endocrinol (Lausanne). 2023;14:1125299.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2440_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.695404","volume":"11","author":"VM Lopez-Ozuna","year":"2021","unstructured":"Lopez-Ozuna VM, Kogan L, Hachim MY, Matanes E, Hachim IY, Mitric C, et al. Identification of predictive biomarkers for lymph node involvement in obese women with endometrial cancer. Front Oncol. 2021;11:695404.","journal-title":"Front Oncol"},{"key":"2440_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1211888","volume":"10","author":"Y Su","year":"2023","unstructured":"Su Y, Zhang Y, Zhou M, Zhang R, Chen S, Zhang L, et al. Genetic alterations in juvenile cervical clear cell adenocarcinoma unrelated to human papillomavirus. Front Med (Lausanne). 2023;10:1211888.","journal-title":"Front Med (Lausanne)"},{"key":"2440_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-019-0938-x","volume":"18","author":"P Laissue","year":"2019","unstructured":"Laissue P. The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis. Mol Cancer. 2019;18:5.","journal-title":"Mol Cancer"},{"key":"2440_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1545952","volume":"15","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhang F, Liang H, Qin X, Mo Y, Chen S, et al. Hippo\/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration. Front Oncol. 2025;15:1545952.","journal-title":"Front Oncol"},{"key":"2440_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.48095\/ccko202516","volume":"38","author":"M Han\u010dinov\u00e1","year":"2025","unstructured":"Han\u010dinov\u00e1 M, Ondru\u0161 D, Ondru\u0161ov\u00e1 M, Mri\u0148\u00e1kov\u00e1 B. Colorectal carcinoma-epidemiology, risk factors, prognostic biomarkers. Klin Onkol. 2025;38:16\u201324.","journal-title":"Klin Onkol"},{"key":"2440_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41392-022-01152-2","volume":"7","author":"C Cai","year":"2022","unstructured":"Cai C, Tang Y-D, Zhai J, Zheng C. The RING finger protein family in health and disease. Signal Transduct Target Ther. 2022;7:300.","journal-title":"Signal Transduct Target Ther"},{"key":"2440_CR24","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1158\/0008-5472.CAN-17-2683","volume":"78","author":"L Liu","year":"2018","unstructured":"Liu L, Zhang Y, Wong CC, Zhang J, Dong Y, Li X, et al. RNF6 promotes colorectal cancer by activating the Wnt\/\u03b2-catenin pathway via ubiquitination of TLE3. Cancer Res. 2018;78:1958\u201371.","journal-title":"Cancer Res"},{"key":"2440_CR25","doi-asserted-by":"publisher","first-page":"e2994","DOI":"10.1038\/cddis.2017.400","volume":"8","author":"R Geng","year":"2017","unstructured":"Geng R, Tan X, Wu J, Pan Z, Yi M, Shi W, et al. RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-\u03baB-IL-8 axis. Cell Death Dis. 2017;8:e2994\u2013e2994.","journal-title":"Cell Death Dis"},{"key":"2440_CR26","doi-asserted-by":"publisher","first-page":"12060","DOI":"10.1080\/21655979.2021.2003664","volume":"12","author":"J Yan","year":"2021","unstructured":"Yan J, Tan M, Yu L, Jin X, Li Y. Ring finger 220 promotes the stemness and progression of colon cancer cells via ubiquitin specific peptidase 22-BMI1 axis. Bioengineered. 2021;12:12060\u20139.","journal-title":"Bioengineered"},{"key":"2440_CR27","doi-asserted-by":"publisher","first-page":"5767535","DOI":"10.1155\/2024\/5767535","volume":"2024","author":"S Mohammadpour","year":"2024","unstructured":"Mohammadpour S, Torshizi Esfahani A, Sarpash S, Vakili F, Zafarjafarzadeh N, Mashaollahi A, et al. Hippo signaling pathway in colorectal cancer: modulation by various signals and therapeutic potential. Anal Cell Pathol. 2024;2024:5767535.","journal-title":"Anal Cell Pathol"},{"key":"2440_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10565-017-9417-6","volume":"34","author":"Q Li","year":"2018","unstructured":"Li Q, Qi F, Meng X, Zhu C, Gao Y. MST1 regulates colorectal cancer stress response via inhibiting Bnip3-related mitophagy by activation of JNK\/p53 pathway. Cell Biol Toxicol. 2018;34:263\u201377.","journal-title":"Cell Biol Toxicol"},{"key":"2440_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.stem.2020.07.003","volume":"27","author":"P Cheung","year":"2020","unstructured":"Cheung P, Xiol J, Dill MT, Yuan W-C, Panero R, Roper J, et al. Regenerative reprogramming of the intestinal stem cell state via Hippo signaling suppresses metastatic colorectal cancer. Cell Stem Cell. 2020;27:590-604.e599.","journal-title":"Cell Stem Cell"},{"key":"2440_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02623-w","volume":"22","author":"X Liu","year":"2022","unstructured":"Liu X, Quan J, Shen Z, Zhang Z, Chen Z, Li L, et al. Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1\/LATS2\/YAP1 signaling pathway in colorectal cancer. Cancer Cell Int. 2022;22:205.","journal-title":"Cancer Cell Int"},{"key":"2440_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00639-1","volume":"18","author":"L Hu","year":"2020","unstructured":"Hu L, Wang J, Wang Y, Wu L, Wu C, Mao B, et al. LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP. Cell Commun Signal. 2020;18:148.","journal-title":"Cell Commun Signal"},{"key":"2440_CR32","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1523\/JNEUROSCI.0035-11.2011","volume":"31","author":"L Xiao","year":"2011","unstructured":"Xiao L, Chen D, Hu P, Wu J, Liu W, Zhao Y, et al. The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death. J Neurosci. 2011;31:9611\u20139.","journal-title":"J Neurosci"},{"key":"2440_CR33","doi-asserted-by":"publisher","first-page":"42987","DOI":"10.1074\/jbc.M208538200","volume":"277","author":"H Glantschnig","year":"2002","unstructured":"Glantschnig H, Rodan GA, Reszka AA. Mapping of MST1 kinase sites of phosphorylation. J Biol Chem. 2002;277:42987\u201396.","journal-title":"J Biol Chem"},{"key":"2440_CR34","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1038\/onc.2015.476","volume":"36","author":"L Li","year":"2016","unstructured":"Li L, Fang R, Liu B, Shi H, Wang Y, Zhang W, et al. Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth. Oncogene. 2016;36:4048\u201357.","journal-title":"Oncogene"},{"key":"2440_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/cas.16091","volume":"115","author":"Y Gu","year":"2024","unstructured":"Gu Y, Ding C, Yu T, Liu B, Tang W, Wang Z, et al. SIRT7 promotes Hippo\/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1. Cancer Sci. 2024;115:1209\u201323.","journal-title":"Cancer Sci"},{"key":"2440_CR36","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/cas.16134","volume":"115","author":"B Shu","year":"2024","unstructured":"Shu B, Zhou Y, Lei G, Peng Y, Ding C, Li Z, et al. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1\/YAP pathway. Cancer Sci. 2024;115:1476\u201391.","journal-title":"Cancer Sci"},{"key":"2440_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13578-024-01329-y","volume":"14","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang J, Chen Y, Liang W, Liu H, Du R, et al. CAFs-derived lactate enhances the cancer stemness through inhibiting the MST1 ubiquitination degradation in OSCC. Cell Biosci. 2024;14:144.","journal-title":"Cell Biosci"},{"key":"2440_CR38","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401895RR","volume":"39","author":"Z Lao","year":"2025","unstructured":"Lao Z, Chen X, Pan B, Fang B, Yang W, Qian Y. Pharmacological regulators of Hippo pathway: advances and challenges of drug development. FASEB J. 2025;39:e70438.","journal-title":"FASEB J"},{"key":"2440_CR39","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1158\/1535-7163.MCT-13-0918","volume":"13","author":"D Basu","year":"2014","unstructured":"Basu D, Lettan R, Damodaran K, Strellec S, Reyes-Mugica M, Rebbaa A. Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of Hippo, TGF-\u03b2, and Wnt signaling pathways. Mol Cancer Ther. 2014;13:1457\u201367.","journal-title":"Mol Cancer Ther"},{"key":"2440_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9357","volume":"6","author":"Z Meng","year":"2015","unstructured":"Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, et al. MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway. Nat Commun. 2015;6:8357.","journal-title":"Nat Commun"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02440-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:02:56Z","timestamp":1790452976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02440-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2440"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02440-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Cancer and paracancerous tissue samples from CRC patients were collected after informed consent of the patients and approval by the Ethics Committee of the Third People\u2019s Hospital of Chengdu (Ethics of Chengdu Third Hospital 2025-S-263). All animal experiments were conducted in accordance with the guidelines of the ethics committee and approved by Experimental Animal Welfare and Ethics Committee of Wuhan Whupenn life science Co., Ltd (LBSM2025013).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}